Libra Wealth’s AbbVie ABBV Stock Holding History

Libra Wealth’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$638K	Buy	2,536 +150	+6%	+$32.3K	0.16%	41
2026 Q1	$519K	Hold	2,386	–	–	0.15%	46
2025 Q4	$545K	Sell	2,386 -106	-4%	-$24.1K	0.15%	45
2025 Q3	$577K	Hold	2,492	–	–	0.17%	42
2025 Q2	$463K	Buy	2,492 +75	+3%	+$13.9K	0.15%	47
2025 Q1	$506K	Buy	2,417 +6	+0.2%	+$1.17K	0.19%	41
2024 Q4	$428K	Sell	2,411 -100	-4%	-$18.4K	0.17%	39
2024 Q3	$496K	Hold	2,511	–	–	0.2%	39
2024 Q2	$431K	Hold	2,511	–	–	0.19%	38
2024 Q1	$457K	Sell	2,511 -310	-11%	-$53.4K	0.2%	39
2023 Q4	$437K	Sell	2,821 -200	-7%	-$29.2K	0.22%	36
2023 Q3	$450K	Hold	3,021	–	–	0.25%	32
2023 Q2	$407K	Hold	3,021	–	–	0.22%	33
2023 Q1	$481K	Hold	3,021	–	–	0.28%	32
2022 Q4	$488K	Sell	3,021 -114	-4%	-$17.5K	0.01%	36
2022 Q3	$421K	Buy	3,135 +75	+2%	+$10.8K	0.27%	34
2022 Q2	$469K	Hold	3,060	–	–	0.34%	25
2022 Q1	$496K	Hold	3,060	–	–	0.28%	18
2021 Q4	$414K	Buy	+3,060	New	+$361K	0.27%	15

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Libra Wealth's ABBV Position: Q2 2026 in Review

Libra Wealth increased its AbbVie (ABBV) stake by 6.3% in Q2 2026, buying an estimated $32.3K and bringing the position to 2,536 shares worth $638K. The position accounts for 0.16% of the portfolio, ranked #41.

Libra Wealth first reported a position in ABBV in Q4 2021 and has held it in 19 quarters since. 4,187 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Libra Wealth held 2,536 shares of AbbVie worth $638K as of Q2 2026.
Libra Wealth bought 150 AbbVie shares in Q2 2026, an estimated $32.3K.
AbbVie made up 0.16% of Libra Wealth's portfolio in Q2 2026, its #41 holding.
Libra Wealth first reported a position in AbbVie in Q4 2021 and has held it in 19 quarters since.
4,187 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Libra Wealth's 13F filing for Q2 2026, filed 6 Aug 2026.